萬馬科技(300698.SZ):子公司優咔科技主營車聯網連接與生態運營產品與服務
格隆匯7月17日丨萬馬科技(300698.SZ)在投資者互動平台表示,公司子公司優咔科技主營車聯網連接與生態運營產品與服務。其研發的自動駕駛工具鏈,主要是為下游傳統主機廠提供自動駕駛算法研發的工具,有助於智能駕駛領域技術水平的提升。與行業領先車企相比,國內車企在自動駕駛數據閉環的數據、算力方面尚處於起步階段。優咔科技正與相關企業進行交流合作,有進一步進展並符合披露要求時會進行披露。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.